3C-E
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
3C-E, also known as 4-ethoxy-3,5-dimethoxyamphetamine or as α-methylescaline (3C-escaline), is a psychedelic drug of the phenethylamine, amphetamine, and 3C families related to 3,4,5-trimethoxyamphetamine (TMA). It is the amphetamine (3C) analogue of escaline.
3C-E, also known as 4-ethoxy-3,5-dimethoxyamphetamine or as α-methylescaline (3C-escaline), is a psychedelic drug of the phenethylamine, amphetamine, and 3C families related to 3,4,5-trimethoxyamphetamine (TMA). It is the amphetamine (3C) analogue of escaline. ==Use and effects== In his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists 3C-E's dose as 30 to 60 mg orally and its duration as 8 to 12 hours. Per other sources, it has an estimated typical dose of 45 mg orally. The drug has about the same potency as escaline. The effects of 3C-E have been described as including strong visuals, closed-eye imagery like bright colors and distinct shapes, complex fantasy, strangeness, unworldliness, and unreality, an eerie state of awareness, fluctuating erotic and anti-erotic feelings, "exquisite sensitivity", heavy body discomfort, feelings of toxicity, nausea, muscle tremors, malaise, and slight teeth clenching. Shulgin concluded that it was a fascinating compound, but that it was a little too heavy on the body for most subjects. ==Interactions== ==Pharmacology== ===Pharmacodynamics=== 3C-E is a potent serotonin 5-HT 2A receptor agonist and also interacts with other serotonin receptors and targets. It produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents. ==Chemistry== ===Synthesis=== The chemical synthesis of 3C-E has been described. ===Analogues=== Analogues of 3C-E include TMA, MEM, 3C-FE, 3C-DFE, and 3C-TFE, among others. ==History== 3C-E was first described in the scientific literature by Benington and colleagues in 1954. Alexander Shulgin and colleagues reported an active dose of 40 mg orally based on unpublished findings in a 1978 literature review. Subsequently, Shulgin further reported the properties and effects of 3C-E in his book PiHKAL (Phenethylamines I Have Known and Loved) in 1991. The drug was encountered as a novel designer drug in Europe in 2013. ==Society and culture== ===Legal status=== ====Canada==== It is a controlled substance in Canada under phenethylamine blanket-ban language.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1371210259 under CC BY-SA 4.0; modifications have been made.